Canada_IPAP - Anglo-Canadian Collaboration on Antimicrobial resistance

Canada_IPAP - 英加抗微生物药物耐药性合作

• 批准号: BB/X012840/1
• 负责人: Zhugen Yang
• 金额: $ 19.33万
• 依托单位: CRANFIELD UNIVERSITY
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FX012840%2F1
• 关键词: Canada_IPAP; Anglo; Canadian; Collaboration; Antimicrobial

Antimicrobial resistance (AMR) is a major public health concern as the proliferation of antibiotic-resistant bacteria increasingly reduces the effectiveness of our most widely used antibiotics in the treatment of bacterial diseases. The current revolution in biosciences is creating new tools that offer the chance to tackle AMR issues in the environment and create 'future-proof' technologies for new areas of application, targeting AMR issues. Successful exploitation depends on combining an enhanced understanding of the fundamental science with an ability to apply and deploy in the field for real-time monitoring to better understand the emergence and dissemination of AMR in the environment. The Anglo-Canadian Collaboration on Antimicrobial resistance (ACCAMAR) thus aims to strengthen the links between those working at the forefront of microbial genomics, metabolic capabilities, and community interactions; and those designing next-generation environmental protection technologies and human risk exposure and mitigations.

抗生素耐药性（AMR）是一个主要的公共卫生问题，因为耐药性细菌的增殖越来越多地降低了我们最广泛使用的抗生素在治疗细菌性疾病中的有效性。当前的生物科学革命正在创造新的工具，为解决环境中的AMR问题提供机会，并为针对AMR问题的新应用领域创造“面向未来”的技术。成功的利用取决于对基础科学的深入理解与在现场应用和部署实时监测的能力相结合，以更好地了解AMR在环境中的出现和传播。因此，英加抗菌素耐药性合作（ACCAMAR）旨在加强微生物基因组学，代谢能力和社区互动前沿工作人员之间的联系;以及设计下一代环境保护技术和人类风险暴露和缓解的人员。